{{Message}}

Utrecht, 8 January 2021 – Mediq has acquired GD Medical AG, a Switzerland-based distributor of medical devices and supplies for intensive, anesthesia and general care units of hospitals. GD Medical’s portfolio includes innovative products such as blood purification, blood and fluid warming systems, respiratory care, wound care products, pain relief medication pumps and neuromuscular monitoring devices. ‘This acquisition fits perfectly with our strategy to be a leading European provider of medical devices and healthcare products and services for both healthcare institutions and patients’, says Mediq CEO Christian Wojczewski.

GD Medical’s activities are fully complementary to the activities of Mediq Suisse to deliver medical products for ostomy, continence and wound care as well as nursing and facility products. Through its exclusive distributor relations, GD Medical provides a unique assortment of high quality products. Their employees are at the forefront of exciting innovations and have a lot of technical competence. Both teams are excited about this step as it helps us to add value for our customers and to expand our presence in Switzerland.

About GD Medical AG
Based in Freienbach near Zurich, GD Medical AG was founded in 2006 by Gabriel Dürst, who set out to supply hospitals with a range of medical consumables and intensive and general care devices and equipment to support the wellbeing needs of patients. Further information is available at https://gdmedical.ch/.

About Mediq
Every day, millions of patients and the dedicated professionals who care for them rely on the supply of medical devices and care solutions from Mediq. As a reliable partner for patients, healthcare professionals and healthcare insurers, Mediq continuously focuses on improving healthcare outcomes and the affordability of healthcare. Mediq was founded in 1899 and has leading market positions in 13 European countries. The head office is located in Utrecht.

Utrecht, 4 January 2021 – Mediq, leading provider of medical devices and healthcare products and services to patients and healthcare institutions, strengthens its European growth with the acquisition of Replant 4 Care in Hungary. The Budapest-based company is a major player in the local ostomy, wound and continence care market. The transaction combines Replant 4 Care’s strong position in multiple market segments with Mediq’s local market leadership in wound care.

‘The strategic rationale for this combination is highly compelling’, says Christian Wojczewski, Mediq’s CEO. ‘At Mediq, our key priority is continuously raising the bar for care while ensuring healthcare access and affordability. The addition of the Replant 4 Care team allows us to expand into underserved market segments in Hungary. Leveraging the complementary strengths of both companies, we will be even better positioned to help those with a chronic or serious health issue.’

About Replant 4 Care
Replant 4 Care is a privately owned company that employs around 60 people (FTE) and has over 20 years of homecare experience. Replant 4 Care is market leader in ostomy care and the third largest wound care supplier in Hungary.

About Mediq
Every day, millions of patients and the dedicated professionals who care for them rely on the supply of medical devices and care solutions from Mediq. As a reliable partner for patients, healthcare professionals and healthcare insurers, Mediq continuously focuses on improving healthcare outcomes and the affordability of healthcare. Mediq was founded in 1899 and has leading market positions in 13 European countries. The head office is located in Utrecht.

22 October 2020 - Mediq intends to expand its position in the Benelux through the acquisition of Eurocept Homecare and Da Vinci Kliniek, both part of Eurocept Group. The acquisition is subject to approvals by regulatory authorities and expected to be completed in the upcoming months. Eurocept Homecare provides specialised medical care and ambulatory medical technology in the patient's home. Da Vinci Kliniek is a leading complex wound care and hyperbaric oxygen therapy expertise centre with six clinics across the Netherlands. Around 400 people work at these two organisations.

Christian Wojczewski, CEO Mediq Group: ‘Mediq Group is a leading international provider of medical devices and healthcare services. This acquisition in the Netherlands will complement and strengthen our portfolio of care solutions aimed at improving the quality of life for patients while making a contribution to keep healthcare affordable for everyone.’

Arjen Linders, Executive Vice President Benelux at Mediq adds: ‘With the complementary portfolios of Eurocept Homecare and Da Vinci Kliniek, we can provide better healthcare services outside the hospital. This is an excellent match with what we do best at Mediq: helping people with medical needs live their lives to the full potential and being there when they need us. There is a strong cultural fit between our respective organisations and we look forward to combining our strengths to drive our unique value proposition.’

Mike van Woensel, CEO Eurocept Group: ‘We are a leading pioneer in the field of specialised medical homecare and treatment for wound healing as well as skin and tissue damage. Mediq provides the scale and future-proof infrastructure to drive further development and growth. Furthermore, pooling our resources offers extra room to invest in technological innovation and digitisation. We have a lot to offer each other.’

Mediq, the European health care products and service partner for healthcare consumers, professionals and institutions, has acquired H&R Healthcare Ltd. A recognized leader in distribution of wound care products, H&R Healthcare significantly strengthens Mediq’s footprint in the UK. “Mediq is constantly innovating and investing in collaboration with healthcare providers to enable people with an illness or chronic health condition to live their lives on their own terms,” says Mediq Chief Executive Christian Wojczewski. “H&R Healthcare is the fastest growing distributor of our own brand wound care products. We look forward to working with their management and employees to provide the primary and secondary care market with the best possible products and services, specialist education and support.”

“Mediq and H&R Healthcare share a passion for delivering innovation to drive improved patient outcomes while simultaneously lowering the cost of delivering healthcare. Another thing that we have in common is our focus on outstanding products that meet patients’ needs and offer excellent value to the NHS”, adds Mike Hoskins, managing director of H&R Healthcare. “This transaction allows H&R Healthcare to grow its business in existing markets and expand in markets such as ostomy and continence care. Also, we will leverage and build upon our mutual wound care expertise to support the ongoing education of clinicians within the medical sector and develop new innovations that improve the health and well-being of patients.”

H&R Healthcare
H&R Healthcare was established in 2006, and has become one of the UK’s fastest growing medical sales and marketing distribution companies. H&R Healthcare represents world-class manufacturers of advanced wound management, compression, infection control, lymphoedema and skin protection products. All products are carefully selected to offer the best overall value to the NHS, measured by patient outcomes and overall cost effectiveness. The company is based in Hull and employs around 40 people.

Mediq.com is using cookies

We use cookies to make Mediq websites easier to use, to deliver a personalised experience on our websites, and to better tailor our products, services and websites to your interests and needs.